SCHEMBL2803989

SCHEMBL2803989

COc1ccc(CCNc2ncc3c(n2)-c2ccccc2C(c2ccc(F)cc2)C3)cc1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.51
FGFR2 P21802 2/20 0.51
CSF1R P07333 1/20 0.51
FGFR3 P22607 1/20 0.51
MAPT P10636 2/20 0.47
TP53 P04637 1/20 0.47
LMNA P02545 2/20 0.43
TSHR P16473 2/20 0.43
CNR2 P34972 1/20 0.43
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
IGF1R P08069 1/20 0.41
CCNT1 O60563 1/20 0.41
CCNA2 P20248 1/20 0.41
CDK2 P24941 1/20 0.41
CDK9 P50750 1/20 0.41
GAA P10253 3/20 0.40
POLB P06746 2/20 0.40
APP P05067 2/20 0.40
BCHE P06276 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2804714 0.93 FGFR1 (0.50) FGFR1FGFR2CSF1RFGFR3MAPT
SCHEMBL2804578 0.92 FGFR1 (0.46) FGFR1FGFR2CSF1RFGFR3LMNA
SCHEMBL2802111 0.90 FGFR1 (0.49) FGFR1FGFR2CSF1RFGFR3MAPT
SCHEMBL2803494 0.87 FGFR1 (0.47) FGFR1FGFR2CSF1RFGFR3CNR2
SCHEMBL2806906 0.86 CSF1R (0.51) FGFR1FGFR2CSF1RFGFR3MAPT
SCHEMBL2802833 0.85 FGFR1 (0.45) FGFR1FGFR2CSF1RFGFR3CNR2
SCHEMBL2803237 0.85 FGFR1 (0.52) FGFR1FGFR2CSF1RFGFR3MAPT
SCHEMBL2806265 0.84 FGFR1 (0.46) FGFR1FGFR2CSF1RFGFR3TP53
SCHEMBL2803964 0.84 FGFR1 (0.55) FGFR1FGFR2CSF1RFGFR3MAPT
SCHEMBL2806030 0.83 FGFR1 (0.44) FGFR1FGFR2CSF1RFGFR3TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078421-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 FGFR1 530/4885FGFR2 511/4885CSF1R 4606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.